Assessing Autodesk (ADSK) Valuation After Earnings Beat Workforce Cuts And AI Investment Shift

Advertisement

Why Autodesk (ADSK) Is Back in Focus

Autodesk (ADSK) is back on investors’ radar after management reported better than expected quarterly results, announced a 7% workforce reduction, and signaled higher investment in AI, cloud, and construction platforms.

See our latest analysis for Autodesk.

Autodesk’s US$251.17 share price reflects a mixed year, with a 30 day share price return of 8.63%, a 90 day share price return of 14.66%, and a year to date share price return of 12.40%. The 3 year total shareholder return of 26.15% contrasts with a modest 1 year total shareholder return decline of 1.28% as investors weigh strong quarterly results, workforce reductions, and heavier AI and cloud spending.

If Autodesk’s AI push has your attention, it may be a suitable moment to see what else is shaping the theme, starting with 62 profitable AI stocks that aren't just burning cash as potential ideas for further research.

With Autodesk delivering better than expected results, planning workforce cuts, and leaning harder into AI and cloud at a share price of US$251.17, you have to ask yourself: is there real upside left here, or is the market already paying for future growth?

Most Popular Narrative: 24.3% Undervalued

With Autodesk last closing at $251.17 against a narrative fair value of $331.75, the most followed view sees meaningful upside built into its long term cash flows, using an 8.63% discount rate to bring those future expectations back to today.

Accelerating adoption of cloud based platforms such as Autodesk Construction Cloud and Fusion 360 and ongoing rollout of subscription and SaaS models are increasing recurring revenue, improving revenue visibility, and improving net margin stability due to higher operating leverage and sales efficiency improvements.

Read the complete narrative.

Curious what kind of revenue runway and margin lift would need to line up to support that higher fair value? The most followed narrative leans on a specific earnings path, firmer profitability, and a richer future earnings multiple, all wired together into one set of assumptions you might want to test for yourself.

Result: Fair Value of $331.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside view could be knocked off course if lower cost or open source rivals squeeze Autodesk’s pricing power, or if newer AI tools outpace its own offerings.

Find out about the key risks to this Autodesk narrative.

Next Steps

If this bullish narrative feels compelling but you want your own angle, now is the time to look through the numbers and sentiment yourself. Start with 4 key rewards.

Looking for more investment ideas?

Do not stop your research with just one company. Broaden your watchlist with other ideas that fit your style so you are not relying on a single theme.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ADSK

Autodesk

Engages in the provision of 3D design, engineering, and entertainment technology solutions worldwide.

Outstanding track record with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
85 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
193 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0